Elsevier has announced that applications and nominations for The Hive, its innovation hub for biotech and pharmaceutical startups, are now open
A powerful computer system capable of revolutionising the UK’s ability to plan for extreme events, such as flooding and power outages, is being designed as part of a government scheme to increase the nation’s resiliency to extreme weather events
At the European Physical Society Conference on High Energy Physics (EPS-HEP) in Venice, the LHCb experiment at CERN’s Large Hadron Collider has reported the observation of a new particle with two heavy quarks
A team of researchers from Peter the Great St Petersburg Polytechnic University (SPbPU) Computer-Aided Engineering Centre of Excellence (CompMechLab) has announced that it has created a protective container with some of the world’s best energy absorption characteristics
Rodin Therapeutics, a venture-backed biotechnology company that develops therapeutics for neurological disorders has announced that it uses Qlucore Omics Explorer to characterise its compounds response to treatment.
SolveBio and Elsevier have announced a collaboration to integrate the use of Pathway Studio, Elsevier’s database of biological molecular interactions and curated pathways
IBM has announced it has built and tested its most powerful universal quantum computing processors to date.
High-Performance Computing (HPC) storage and data analytics integrator, OCF, is supporting scientific research at the UK Atomic Weapons Establishment (AWE), with the design, testing and implementation of a new HPC, cluster and separate big data storage system
Cellular Biomedicine Group and GE Healthcare, have announced that they have established a strategic research collaboration to co-develop certain high-quality industrial control processes in CAR-T and stem cell manufacturing
Optibrium is aiming to develop products with improved metabolism prediction capabilities through a new collaborative parternship with the non-profit organisation and educational charity, Lhasa Limited.
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
